Vaxcyte Inc (PCVX)

SG&A Expenses

$34.93M

Quarterly · Period ending: · USD

PCVX logo

PCVX SG&A Expenses

Latest reported$34.93M
PCVX Quarterly SG&A Expenses ($1.32M → $34.93M)
High-resolution chart · PNG

PCVX sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vaxcyte Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
34,925,000
33,071,000
32,223,000
32,447,000
32,040,000
32,659,000
28,555,000
22,988,000
21,474,000
19,885,000
17,526,000
15,605,000
14,456,000
13,112,000
11,952,000
10,898,000
9,417,000
7,543,000
6,772,000
6,523,000
6,079,000
5,885,000
4,792,000
4,898,000
3,046,000
3,281,000
2,457,000
2,510,000
2,264,000
1,316,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.